Cibus, Inc.
- CBUS
- NASDAQ
- Biotechnology
- Gene Editing (Crops)
- Agricultural Traits
$1.37
Today +4.58%Quote Oct 20, 2026, 07:09 PM UTC
−18.63%over the last month
Max drawdown −24.6%From 1-month high −23.4%3 months −29.6%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Cibus
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients.
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Employees
118
Founded
2010
Market value
$104.7M
Quote Oct 20
Floor
$1.36
0.4% below price
Resistance
$1.38
1.0% above price
Price vs analyst targets
4 analysts
Lowest target
$10.50Highest target
$12.50
$10.50Highest target
$12.50
- Price $1.37
- Average target $11.50
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 739% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about CBUSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free